Pharmaceutical product containing blood constituents and or kDa, and the use of the same for the prophylaxis and treatment of defects of the immune system

Details for Australian Patent Application No. 2005287727 (hide)

Owner Salama, Z.

Inventors Salama, Zoser B.

Agent Eagar & Buck

Pub. Number AU-A-2005287727

PCT Pub. Number WO2006/032269

Priority 10/948,753 24.09.04 US; 04090376.7 24.09.04 EP

Filing date 26 September 2005

Wipo publication date 30 March 2006

International Classifications

A61K 35/14 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution - Blood

A61P 37/04 (2006.01) Drugs for immunological or allergic disorders

Event Publications

10 May 2007 PCT application entered the National Phase

  PCT publication WO2006/032269 Priority application(s): WO2006/032269

24 September 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005287729-2-acylaminothiazole derivatives

2005287726-Treatment of defects of cellular immunity with leukocyte homogenates having a molecular weight of less than 10,000 dalton